Sectors
SPRY
ARS Pharmaceuticals, Inc.
6.00
2 x 3.89
2 x 6.72
bid
ask
+
0.11
1.87%
2 @ 07:30 PM
6.00 +0.00 (0.00%)
| Ytd | -48.50% | |
| 1y | -48.36% |
5.62
day range
6.09
4.91
52 week range
13.15
| Open | 5.83 | Prev Close | 5.89 | Low | 5.62 | High | 6.09 | Mkt Cap | 596.68M |
| Vol | 1.98M | Avg Vol | 2.01M | EPS | -2.18 | P/E | N/A | Forward P/E | -11.01 |
| Beta | 0.83 | Short Ratio | 13.70 | Inst. Own | 95.47% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-10 | 50-d Avg | 6.86 | 200-d Avg | 8.63 | 1yr Est | 28.80 |
| Income Statement | |||
| Total Revenue | 33.66M | ||
| Revenues (USD) | 33.66M | ||
| Cost of Revenue | 12.85M | ||
| Gross Profit | 20.81M | ||
| Operating Expenses | 82.28M | ||
| Research and Development Expense | 4.70M | ||
| Selling, General and Administrative Expense | 77.58M | ||
| Operating Income | -61.46M | ||
| Interest Expense | 2.48M | ||
| Net Income | -62.34M | ||
| Net Income Common Stock | -62.34M | ||
| Net Income Common Stock (USD) | -62.34M | ||
| Consolidated Income | -62.34M | ||
| Earnings per Basic Share | -0.63 | ||
| Earnings per Basic Share (USD) | -0.63 | ||
| Earnings per Diluted Share | -0.63 | ||
| Earning Before Interest & Taxes (EBIT) | -59.86M | ||
| Earning Before Interest & Taxes (USD) | -59.86M | ||
| Weighted Average Shares | 99.31M | ||
| Weighted Average Shares Diluted | 99.31M | ||
| Balance Sheet | |||
| Cash and Equivalents | 8.16M | ||
| Cash and Equivalents (USD) | 8.16M | ||
| Investments | 135.68M | ||
| Investments Current | 135.68M | ||
| Trade and Non-Trade Receivables | 46.84M | ||
| Current Assets | 211.51M | ||
| Property, Plant & Equipment Net | 2.09M | ||
| Total Assets | 249.50M | ||
| Total Debt | 171.60M | ||
| Current Liabilities | 60.86M | ||
| Debt Non-Current | 171.60M | ||
| Total Liabilities | 236.98M | ||
| Accumulated Retained Earnings (Deficit) | -417.56M | ||
| Accumulated Other Comprehensive Income | -140.00K | ||
| Shareholders Equity | 12.51M | ||
| Shareholders Equity (USD) | 12.51M | ||
| Assets Non-Current | 37.99M | ||
| Total Debt (USD) | 171.60M | ||
| Deferred Revenue | 535.00K | ||
| Goodwill and Intangible Assets | 13.90M | ||
| Inventory | 30.73M | ||
| Liabilities Non-Current | 176.12M | ||
| Trade and Non-Trade Payables | 59.73M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 416.00K | ||
| Net Cash Flow from Financing | 3.20M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -16.16M | ||
| Issuance (Purchase) of Equity Shares | 786.00K | ||
| Issuance (Repayment) of Debt Securities | 2.41M | ||
| Net Cash Flow from Investing | 41.57M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 41.57M | ||
| Net Cash Flow from Operations | -60.93M | ||
| Share Based Compensation | 12.40M | ||